Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | KCNN2 | Q9H2S1 | 2/20 | 0.32 |
| ▸ | KCNN3 | Q9UGI6 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25451756 | 0.89 | EDNRB (0.35) | EDNRBEDNRAGABRA1GABRB2KCNN2 | |
| SCHEMBL25455910 | 0.87 | NPC1 (0.34) | KCNN2KCNN3 | |
| SCHEMBL25450662 | 0.87 | EDNRB (0.36) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL26014634 | 0.86 | EDNRB (0.36) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL26013432 | 0.83 | EDNRB (0.36) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL26013324 | 0.81 | EDNRA (0.38) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL25445901 | 0.81 | LMNA (0.37) | — | |
| SCHEMBL25450506 | 0.81 | LMNA (0.37) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL25450383 | 0.80 | EDNRB (0.36) | EDNRBEDNRAGABRA1GABRB2 | |
| SCHEMBL25451685 | 0.80 | LMNA (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240130-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-27 | — | — | US | disclosed |
| US-11653558-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240130-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, LBR, RBM3 | EDNRB 1282/4885EDNRA 1544/4885GABRA1 2970/4885 |
| US-11653558-B2 | Organic electroluminescent materials and devices | OSBPL3, LBR, LOXL3 | EDNRB 1202/4885EDNRA 1558/4885GABRA1 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.